tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Avalo Therapeutics Advances in Hidradenitis Suppurativa Treatment with AVTX-009 Study
PremiumCompany AnnouncementsAvalo Therapeutics Advances in Hidradenitis Suppurativa Treatment with AVTX-009 Study
2M ago
Oppenheimer healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Oppenheimer healthcare analysts hold an analyst/industry conference call
2M ago
Avalo Therapeutics management to meet with Piper Sandler
Premium
The Fly
Avalo Therapeutics management to meet with Piper Sandler
2M ago
Avalo Therapeutics appoints Kevin Lind to board of directors
PremiumThe FlyAvalo Therapeutics appoints Kevin Lind to board of directors
3M ago
Avalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
Premium
The Fly
Avalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
3M ago
Oppenheimer buyers of Avalo Therapeutics ahead of lutikizumab data
Premium
The Fly
Oppenheimer buyers of Avalo Therapeutics ahead of lutikizumab data
3M ago
Target downgraded, Salesforce upgraded: Wall Street’s top analyst calls
PremiumThe FlyTarget downgraded, Salesforce upgraded: Wall Street’s top analyst calls
4M ago
Avalo Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Avalo Therapeutics initiated with an Overweight at Cantor Fitzgerald
4M ago
Avalo Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Avalo Therapeutics Reports Q2 2025 Financial Results
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100